Does RIBOCICLIB Cause Breast cancer? 788 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 788 reports of Breast cancer have been filed in association with RIBOCICLIB (KISQALI). This represents 2.8% of all adverse event reports for RIBOCICLIB.
788
Reports of Breast cancer with RIBOCICLIB
2.8%
of all RIBOCICLIB reports
190
Deaths
167
Hospitalizations
How Dangerous Is Breast cancer From RIBOCICLIB?
Of the 788 reports, 190 (24.1%) resulted in death, 167 (21.2%) required hospitalization, and 30 (3.8%) were considered life-threatening.
Is Breast cancer Listed in the Official Label?
Yes, Breast cancer is listed as a known adverse reaction in the official FDA drug label for RIBOCICLIB.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Breast cancer?
RANITIDINE (45,666)
LETROZOLE (1,393)
ETANERCEPT (1,303)
METHOTREXATE (936)
ADALIMUMAB (894)
INFLIXIMAB (789)
FULVESTRANT (684)
DENOSUMAB (671)
ABATACEPT (617)
INTERFERON BETA-1A (610)
Which RIBOCICLIB Alternatives Have Lower Breast cancer Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN